US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 37.370
  • +1.770+4.97%
Close Dec 2 16:00 ET
  • 37.370
  • 0.0000.00%
Post 16:02 ET
1.03BMarket Cap-8891P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.15%-10.58M
-16.79%-15.8M
-87.04%-23.94M
-1,375.92%-60.38M
-180.99%-20.97M
-13.09M
-13.52M
-12.8M
24.16%-4.09M
-7.46M
Net income from continuing operations
45.90%-10.22M
30.37%-10.25M
-31.40%-16.65M
-547.19%-69.97M
-151.27%-23.69M
---18.88M
---14.73M
---12.67M
-42.95%-10.81M
---9.43M
Operating gains losses
--0
--0
6,443.75%1.05M
-485.71%-123K
-5,280.00%-269K
--106K
--24K
--16K
-102.56%-21K
---5K
Depreciation and amortization
150.00%10K
350.00%18K
66.67%5K
87.50%15K
33.33%4K
--4K
--4K
--3K
300.00%8K
--3K
Change In working capital
-121.14%-1.21M
-717.23%-6.2M
-3,018.69%-9.01M
56.52%9.41M
87.30%2.98M
--5.72M
--1M
---289K
421.88%6.01M
--1.59M
-Change in prepaid assets
-169.51%-285K
133.90%119K
-221.60%-518K
136.03%761K
122.64%276K
--410K
---351K
--426K
-13,100.00%-2.11M
---1.22M
-Change in payables and accrued expense
-117.40%-923K
-467.21%-4.94M
-1,088.11%-8.5M
5.96%8.64M
-3.77%2.7M
--5.31M
--1.35M
---715K
596.84%8.15M
--2.81M
-Change in other current assets
--0
----
----
134.48%10K
--0
--0
----
----
-1,350.00%-29K
--0
Cash from discontinued investing activities
Operating cash flow
19.15%-10.58M
-16.79%-15.8M
-87.04%-23.94M
-1,375.92%-60.38M
-180.99%-20.97M
---13.09M
---13.52M
---12.8M
24.16%-4.09M
---7.46M
Investing cash flow
Cash flow from continuing investing activities
-247.38%-62.23M
-266.10%-98.39M
300,100.00%18M
-79,956.76%-29.62M
505,866.67%15.17M
-17.91M
-26.88M
-6K
-311.11%-37K
-3K
Net PPE purchase and sale
---186K
-454.17%-133K
--0
18.92%-30K
--0
--0
---24K
---6K
-311.11%-37K
---3K
Net investment purchase and sale
-246.34%-62.04M
-265.93%-98.26M
--18M
---29.59M
--15.17M
---17.91M
---26.85M
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-247.38%-62.23M
-266.10%-98.39M
300,100.00%18M
-79,956.76%-29.62M
505,866.67%15.17M
---17.91M
---26.88M
---6K
-311.11%-37K
---3K
Financing cash flow
Cash flow from continuing financing activities
5,349.65%29.82M
-2.14M
105.90%171.27M
166.67%80.7M
-109.43%-1.91M
-568K
0
83.18M
32.93%30.26M
20.26M
Net common stock issuance
--29.77M
---3.56M
--53.39M
----
----
--0
--0
--0
----
----
Net preferred stock issuance
--0
--0
--0
175.37%82.98M
--0
--0
--0
--82.98M
32.37%30.13M
--20.24M
Proceeds from stock option exercised by employees
--57K
--3.41M
111.82%430K
57.36%203K
--0
--0
--0
--203K
--129K
--15K
Net other financing activities
---13K
---1.99M
--117.45M
---2.48M
---1.91M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
5,349.65%29.82M
---2.14M
105.90%171.27M
166.67%80.7M
-109.43%-1.91M
---568K
--0
--83.18M
32.93%30.26M
--20.26M
Net cash flow
Beginning cash position
13.08%84.15M
74.60%200.47M
-20.93%35.14M
142.75%44.44M
35.37%42.85M
--74.42M
--114.82M
--44.44M
1,837.25%18.31M
--31.65M
Current changes in cash
-36.17%-42.99M
-187.93%-116.32M
134.93%165.33M
-135.59%-9.3M
-160.27%-7.71M
---31.57M
---40.4M
--70.38M
50.52%26.13M
--12.79M
End cash Position
-3.94%41.16M
13.08%84.15M
74.60%200.47M
-20.93%35.14M
-20.93%35.14M
--42.85M
--74.42M
--114.82M
142.75%44.44M
--44.44M
Free cash flow
17.73%-10.77M
-17.57%-15.93M
-86.95%-23.94M
-1,363.42%-60.41M
-180.87%-20.97M
---13.09M
---13.55M
---12.8M
23.60%-4.13M
---7.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.15%-10.58M-16.79%-15.8M-87.04%-23.94M-1,375.92%-60.38M-180.99%-20.97M-13.09M-13.52M-12.8M24.16%-4.09M-7.46M
Net income from continuing operations 45.90%-10.22M30.37%-10.25M-31.40%-16.65M-547.19%-69.97M-151.27%-23.69M---18.88M---14.73M---12.67M-42.95%-10.81M---9.43M
Operating gains losses --0--06,443.75%1.05M-485.71%-123K-5,280.00%-269K--106K--24K--16K-102.56%-21K---5K
Depreciation and amortization 150.00%10K350.00%18K66.67%5K87.50%15K33.33%4K--4K--4K--3K300.00%8K--3K
Change In working capital -121.14%-1.21M-717.23%-6.2M-3,018.69%-9.01M56.52%9.41M87.30%2.98M--5.72M--1M---289K421.88%6.01M--1.59M
-Change in prepaid assets -169.51%-285K133.90%119K-221.60%-518K136.03%761K122.64%276K--410K---351K--426K-13,100.00%-2.11M---1.22M
-Change in payables and accrued expense -117.40%-923K-467.21%-4.94M-1,088.11%-8.5M5.96%8.64M-3.77%2.7M--5.31M--1.35M---715K596.84%8.15M--2.81M
-Change in other current assets --0--------134.48%10K--0--0---------1,350.00%-29K--0
Cash from discontinued investing activities
Operating cash flow 19.15%-10.58M-16.79%-15.8M-87.04%-23.94M-1,375.92%-60.38M-180.99%-20.97M---13.09M---13.52M---12.8M24.16%-4.09M---7.46M
Investing cash flow
Cash flow from continuing investing activities -247.38%-62.23M-266.10%-98.39M300,100.00%18M-79,956.76%-29.62M505,866.67%15.17M-17.91M-26.88M-6K-311.11%-37K-3K
Net PPE purchase and sale ---186K-454.17%-133K--018.92%-30K--0--0---24K---6K-311.11%-37K---3K
Net investment purchase and sale -246.34%-62.04M-265.93%-98.26M--18M---29.59M--15.17M---17.91M---26.85M--0--------
Cash from discontinued investing activities
Investing cash flow -247.38%-62.23M-266.10%-98.39M300,100.00%18M-79,956.76%-29.62M505,866.67%15.17M---17.91M---26.88M---6K-311.11%-37K---3K
Financing cash flow
Cash flow from continuing financing activities 5,349.65%29.82M-2.14M105.90%171.27M166.67%80.7M-109.43%-1.91M-568K083.18M32.93%30.26M20.26M
Net common stock issuance --29.77M---3.56M--53.39M----------0--0--0--------
Net preferred stock issuance --0--0--0175.37%82.98M--0--0--0--82.98M32.37%30.13M--20.24M
Proceeds from stock option exercised by employees --57K--3.41M111.82%430K57.36%203K--0--0--0--203K--129K--15K
Net other financing activities ---13K---1.99M--117.45M---2.48M---1.91M--------------------
Cash from discontinued financing activities
Financing cash flow 5,349.65%29.82M---2.14M105.90%171.27M166.67%80.7M-109.43%-1.91M---568K--0--83.18M32.93%30.26M--20.26M
Net cash flow
Beginning cash position 13.08%84.15M74.60%200.47M-20.93%35.14M142.75%44.44M35.37%42.85M--74.42M--114.82M--44.44M1,837.25%18.31M--31.65M
Current changes in cash -36.17%-42.99M-187.93%-116.32M134.93%165.33M-135.59%-9.3M-160.27%-7.71M---31.57M---40.4M--70.38M50.52%26.13M--12.79M
End cash Position -3.94%41.16M13.08%84.15M74.60%200.47M-20.93%35.14M-20.93%35.14M--42.85M--74.42M--114.82M142.75%44.44M--44.44M
Free cash flow 17.73%-10.77M-17.57%-15.93M-86.95%-23.94M-1,363.42%-60.41M-180.87%-20.97M---13.09M---13.55M---12.8M23.60%-4.13M---7.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data